跳至主要内容
临床试验/CTRI/2024/07/071348
CTRI/2024/07/071348尚未招募4 期

igating Clip PMS Study: A prospective, single-arm, multi-centre, observational, real-world, post-market surveillancestudy to evaluate the safety and efficacy of MIRUS™ LIGATING CLIP. - NI

Meril Life Sciences Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1 The subject is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form.
  • 2 In the case of a subject and LAR being illiterate, a literate impartial witness is required during consenting.
  • 3 If the subject is not able to write on behalf of the subject, the subjects LAR (Legally acceptable representative) can fill out the informed consent.
  • 4 The subject is willing and able to comply with postoperative scheduled clinical evaluations.
  • 5 Subjects who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained.
  • 6 Subject must be treated with MIRUS™ LIGATING CLIP.
  • 7 The subject must receive treatment for securely gripping the vessel or tissue to provide complete occlusion atraumatically

排除标准

  • 1 Without informed consent, the subject is not eligible for the study.
  • 2. Patients undergoing fallopian tube ligation or renal artery ligation are not eligible for the use of MIRUS™ LIGATING CLIP.

研究者

发起方
Meril Life Sciences Pvt Ltd

相似试验

MIRUS™ LIGATING CLIP applier allows the end user to... | 临床试验